Evidence map›Paper›PMID 33679098›Full record

ArticleJournal of pharmacy & bioallied sciences

Comparison between Branded and Generic Furosemide 40 mg Tablets Using Thermal Gravimetric Analysis and Fourier Transform Infrared Spectroscopy.

Mosab Arafat, Khairi M Fahelelbom, Muhammad K Sarfraz, Mohammad F Bostanudin, Qurat-Ul-Ain Sharif, Anna Esmaeil, Othman A Al Hanbali, Salahdein Aburuz

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmacy & bioallied sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Development and In Vitro Evaluation of Controlled Release ViagraPharmaceuticals (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Mosab ArafatCollege of Pharmacy, Al Ain University, Al Ain, Abu Dhabi, UAE.
Khairi M FahelelbomCollege of Pharmacy, Al Ain University, Al Ain, Abu Dhabi, UAE.
Muhammad K SarfrazCollege of Pharmacy, Al Ain University, Al Ain, Abu Dhabi, UAE.
Mohammad F BostanudinCollege of Pharmacy, Al Ain University, Al Ain, Abu Dhabi, UAE.
Qurat-Ul-Ain SharifCollege of Pharmacy, Al Ain University, Al Ain, Abu Dhabi, UAE.
Anna EsmaeilCollege of Pharmacy, Al Ain University, Al Ain, Abu Dhabi, UAE.
Othman A Al HanbaliFaculty of Pharmacy, The University of Sydney, Sydney, Australia.
Salahdein AburuzCollege of Medicine and Health Sciences, The United Arab Emirates University, Al Ain, UAE.
Al Ain University · AEUniversity of Jordan · JOUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThere has been a long-standing belief that generic drugs are of lower value in comparison to their branded name counterparts. They are in particular under scrutiny due to their low market price. Even though the reduction in costs is largely based on skipping expensive preclinical studies and clinical trials for generic drugs, the purity and quality of the raw materials in the production of generic drugs is debatable. Thus, the objective of the study was to analyze and assess the quality comparability of generic furosemide 40 mg (FSD) tablets to branded product available in the market. MATERIALS AND

methodsQuality control tests, in vitro drug release assessments, and thermal analysis investigations for both analog products of FSD were performed. Various physical parameters related to the tablet quality, such as hardness, weight variation, and friability tests, were examined. In vitro drug release behavior evaluations were conducted according to United States Pharmacopeia (USP) specifications and guidelines, whereas thermal analysis was carried out using thermal gravimetric analysis (TGA), and tablets were further evaluated by Fourier transform infrared (FTIR) spectroscopy.

resultsThe results indicated a significant variation between the two products in terms of hardness, weight variation, and friability. This could be correlated to variation appeared in thermal and spectroscopic spectra between the two products using TGA and FTIR. Drug release of FSD was slightly different between both products following incubation in different pH media (1.2, 3.0, and 6.5; 120 min), however, this was in accordance with USP dissolution requirements as < 80% of drug release was obtained within the first 30 min from each product.

conclusionThis study is a useful example for the independent investigations using thermal and spectroscopic analysis to confirm potential hidden variations between generic and branded products that could not be obtained by the bioequivalence studies.

Indexed as

Dissolution testFourier transform infrared spectroscopyfurosemidequality control testthermal analysisthermal gravimetric analysis

Identifiers

PMID33679098
PMCPMC7909057
OpenAlexW3092536466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.